Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate

dc.contributor.author	Lencer, R.
dc.contributor.author	García-Portilla González, María Paz
dc.contributor.author	Bergmans, P.
dc.contributor.author	Gopal, S.
dc.contributor.author	Mathews, M.
dc.contributor.author	Wooller, A.
dc.contributor.author	Pungor, K.
dc.date.accessioned	2021-11-09T07:32:13Z
dc.date.available	2021-11-09T07:32:13Z
dc.date.issued	2021
dc.identifier.citation	Comprehensive Psychiatry, 107 (2021); doi:10.1016/j.comppsych.2021.152233
dc.identifier.issn	0010-440X
dc.identifier.uri	http://hdl.handle.net/10651/60760
dc.language.iso	eng
dc.relation.ispartof	Comprehensive Psychiatry
dc.rights	© 2021 Los autores. Publicado por Elsevier Inc.
dc.rights	CC Reconocimiento - No Comercial - Sin Obra Derivada 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102125382&doi=10.1016%2fj.comppsych.2021.152233&partnerID=40&md5=2e167a400d61442777c0a4ac198c0a16
dc.title	Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate
dc.type	journal article
dc.identifier.doi	10.1016/j.comppsych.2021.152233
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.comppsych.2021.152233
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Este ítem está sujeto a una licencia Creative Commons